Related Experiment Video
Updated: Nov 1, 2025
12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
8.2K
Comparative effectiveness of robotic and open radical prostatectomy
Rodrigo Rodrigues Pessoa1, Paul Maroni1, Janet Kukreja1
1Division of Urology, University of Colorado Anschutz Medical Center, Aurora, Colorado, USA.
Translational Andrology and Urology
|June 23, 2021
Summary
Robotic radical prostatectomy (RP) and open RP show conflicting evidence on outcomes. This review compares robotic vs. open RP effectiveness, safety, quality of life, and costs, discussing data limitations and future directions.
Area of Science:
- Urology
- Surgical Oncology
- Health Services Research
Background:
- Radical prostatectomy (RP) has evolved from open to minimally-invasive techniques.
- Conflicting evidence exists regarding the comparative effectiveness of different RP approaches.
Purpose of the Study:
- To summarize current literature comparing robotic and open radical prostatectomy (RP).
- To evaluate oncologic results, quality of life, safety, complications, and costs.
- To discuss data limitations and future directions for both surgical methods.
Main Methods:
- Systematic literature review and comparative analysis of existing studies.
- Focus on key outcomes: oncologic control, health-related quality of life (HRQOL), safety, complications, and healthcare costs.
- Critical interpretation of current data limitations.
Main Results:
- Robotic and open RP demonstrate varied outcomes across oncologic results, HRQOL, safety, and cost-effectiveness.
- Significant heterogeneity and limitations exist within the current comparative data.
- Further research is needed to clarify definitive advantages and disadvantages.
Conclusions:
- The comparative effectiveness of robotic versus open radical prostatectomy remains incompletely defined due to data limitations.
- Future research should address existing evidence gaps to guide surgical approach selection.
- Understanding these differences is crucial for optimizing prostate cancer treatment and healthcare delivery.
